In this slides included clinical pharmacy introduction and pharmaceutical care, also explanation about the goals and objectives of the clinical pharmacy requirements
Patient medication adherence, Medication adherence, Causes of medication non-adherence, Problems linked with Medication Non-adherence, Factors affecting medication adherence, Patient related factors, Social and Economic factor, Disease related factor, Health care provider related factors, Therapy related factors, pharmacist role in the medication adherence, role of pharmacist in the medication adherence, monitoring of patient medication adherence, Direct method, Indirect method
In this slides included clinical pharmacy introduction and pharmaceutical care, also explanation about the goals and objectives of the clinical pharmacy requirements
Patient medication adherence, Medication adherence, Causes of medication non-adherence, Problems linked with Medication Non-adherence, Factors affecting medication adherence, Patient related factors, Social and Economic factor, Disease related factor, Health care provider related factors, Therapy related factors, pharmacist role in the medication adherence, role of pharmacist in the medication adherence, monitoring of patient medication adherence, Direct method, Indirect method
Pharmacy and therapeutic committee, PTC, Organization of PTC, Functions of PTC, Automatic stop order, Emergency drug list, ADR and safety monitoring, Role of Pharmacy and therapeutic committee
Medication Adherence , setting up directions .. Ahmed Nouri
presenting the terminology of adherence, statistics of non-adherence and its impact, why do patients have difficulty with treatment, how to measure and how to improve the adherence, in addition to the role of the pharmacist in improving adherence.
This presentation is prepared to enhance the adherence of patient to their specific medication as prescribed by the physician and the role of pharmacist in improving the adherence of patient to their medication including various factors influence the adherence ,methods to measure adherence and methods to improve adherence .
Pharmacy and therapeutic committee, PTC, Organization of PTC, Functions of PTC, Automatic stop order, Emergency drug list, ADR and safety monitoring, Role of Pharmacy and therapeutic committee
Medication Adherence , setting up directions .. Ahmed Nouri
presenting the terminology of adherence, statistics of non-adherence and its impact, why do patients have difficulty with treatment, how to measure and how to improve the adherence, in addition to the role of the pharmacist in improving adherence.
This presentation is prepared to enhance the adherence of patient to their specific medication as prescribed by the physician and the role of pharmacist in improving the adherence of patient to their medication including various factors influence the adherence ,methods to measure adherence and methods to improve adherence .
brief review on clinical pharmacy, drug information centre & patient safety program
The lecture was presented at Al-Mahmoudiya General Hospital as part of the training course for fresh appointed pharmacist at 16/5/2023 at 11 & 15/5/2023
Comprehensive and person centred approach to addressing Polypharmacy in adult...Health Innovation Wessex
The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Comprehensive and person centred approach to addressing Polypharmacy in adult care home residents, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptxraviapr7
b) Clinical Pharmacy
Introduction to Clinical Pharmacy, Concept of clinical pharmacy
Functions and responsibilities of clinical pharmacist, Drug therapy monitoring
Medication chart review, clinical review., pharmacist intervention
Ward round participation, Medication history and Pharmaceutical care.
Dosing pattern and drug therapy based on Pharmacokinetic & disease pattern
BRP Pharmaceuticals is a leader in physician dispensing services that provides instant medication to patients located in Burbank, CA. Visit: http://www.brppharma.com/
medication Adherence defined as the act of filling a new prescription for the first time.
The extent to which the patients take medications as prescribed by the prescriber.
Stop TB Partnership focus group session 10-20-17Bruce Thomas
The Arcady Group founder, Bruce Thomas, led the Stop TB Partnership's Focus Group Workshop On Digital Adherence Technologies. At this meeting, innovators such as Everwell Health (99DOTS), Wisepill Technologies (evriMED medication monitor), Keheala (SMS-based behavioral counseling) and SureAdhere Mobile Technology (V-DOT) were connected with representatives of key NGO implementers and country programs (including Zimbabwe, Philippines, Moldova, and South Africa) to discuss opportunities for experimentation and uptake of digital adherence technologies through TB REACH Wave 6 grants. Bruce and Ram Subbaraman shared new evidence and insights about the importance of treatment adherence to avoid TB relapse.
Patient compliance with medical adviceRavish Yadav
The all the content in this profile is completed by the teachers, students as well as other health care peoples.
thank you, all the respected peoples, for giving the information to complete this presentation.
this information is free to use by anyone.
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
2. DEFINITION
• Patient adherence (or compliance) means correct following of medical advice by the patient.
• Usually the patient takes medication on his own (drug compliance), but the term adherence
may also refer to the use of surgical appliances, like compression stockings, chronic wound
care, self -directed physiotherapy exercises, or attending counselling or other therapy
courses.
• To improve patient adherence, a physician has to build positive physician-patient
relationship.
• Medication adherence is categorised into two main concepts, i.e., adherence and
persistence. Both the concepts are theoretically similar, but adherence is the intensity of
drug use during the duration of therapy, while persistence is the overall duration of drug
therapy.
• WHO defined medication adherence as “ the degree to which the person’s behaviour
corresponds with the agreed recommendations from a health care provider”.
8/25/2022 2
PHARMACY PRACTICE
3. CAUSES OF MEDICATION NON-ADHERENCE
8/25/2022 3
EXTERNAL INFLUENCER PATIENT EXPERIENCES
PHARMACY PRACTICE
5. 1) The patient’s cultural beliefs,
2) Mistrust of health professional (some patients do not agree with the healthcare management),
3) Patients take more drug than prescrib ed when wanted to speed up the response to treatment
4) Patients cannot read the written materials provided by healthcare professional and are afraid to
take medications,
5) Patients start feeling that the treatment is unimportant and stop visiting the health professional,
6) Patients forget to take medication during the daytime,
7) Patients have difficulty in opening the bottles containing medications,
8) Patients have physical limitations and cannot administer the medications as prescribed (e.g., a
patient having severe arthritis cannot take insulin injection),
9) Patients are not financially stable enough to afford the medications,
10) Patients have psychological disorder and fail to understand the need to take the medication, and
11) Healthcare professionals fail to educate th e patients about proper medication use, dose, and
administration techniques.
8/25/2022 5
PHARMACY PRACTICE
6. Determinants of Medication Adherence
• Medication adherence or non -adherence is the result of a complex
interaction among many factors.
• Some of these factors improve the medication adherence of a patient
while some put a negative influence.
• Thus, the prediction of medication adherence is difficult since the
situation is different for each patient.
8/25/2022 6
PHARMACY PRACTICE
7. The factors influencing adherence or any health-related behaviour are divided into
three categories:
1) Predisposing Factors:
These factors include demographic factors of the patients, and also their
knowledge, attitudes, beliefs and perceptions about illness and its severity, cause,
prevention, and treatment.
The Health Belief Model developed in 1974 predicted adherence or other health -
related behaviour changes in terms of certain belief patterns.
The sequence of belief events under this model, which need to occur if the patient
is to be adherent, is as follows:
i) The patients should believe that their health is in danger.
ii) The patients should identify the potential seriousness of the condition in terms
of symptoms, time lost from work, economic difficulties, etc.
iii) After evaluating the conditions, the patient should believe that benefits from
treatment compensate the costs.
iv) The patient should feel the need to adhere to the medication.
8/25/2022 7
PHARMACY PRACTICE
8. • 2) Enabling Factors: These factors are the skills and resources required for
adherence. The term skills refer to the patient’s capability of embracing such
behaviours that will contribute to adherence, e.g., taking an appointment from
the doctor to obtain a prescription. The term resources refer to the availability
and approachability of healthcare facilities such as doctors, pharmacies, clinics, or
hospitals.
• 3) Reinforcing Factors: These factors determine whether or not the patient’s
family members, peers, healthcare providers, the local community , and society
are supportive enough to assist in medication adherence. This support may be
positive or negative, and this depends on the attitude or behaviour of the people
as some may be more influential while the others may be less.
8/25/2022 8
PHARMACY PRACTICE
9. ROLE OF HEALTH CARE PROVIDER TO IMPROVE
MEDICATION ADHERENCE
• 1 LEVEL OF PRESCRIBING
• 2 COMMUNICATING WITH
PATIENTS
8/25/2022 9
PHARMACY PRACTICE
12. Monitoring of Patient Medication Adherence
• Direct Methods
• Direct methods of adherence assessment involve direct observation
of the undergoing therapy, measurement of the drug or metabolite
level and of the biological marker in blood.
• The direct methods are considered to be more robust than the
indirect methods, still they have some limitations.
• For example, patients may hide the pills in their mouth and discard
them later, or they may have varied metabolism that will ultimately
affect serum levels. These direct methods are not used practically for
routine clinical analysis.
8/25/2022 12
PHARMACY PRACTICE
13. • Indirect Methods
Indirect methods of adherence assessment involve:
• patient questionnaires,
• self-reports,
• pill counts,
• rate of prescription refills,
• electronic medication monitors,
• patient diaries,
• patient’s clinical response, and physiological
markers.
Patient’s self -report, pill counts, and pharmacy
refills are the most commonly used indirect methods.
8/25/2022 13
PHARMACY PRACTICE
15. • Morisky’s Medication Adherence Scale (MMAS) was designed to differentiate between the patients
who are poorly adherent and the patients who are medium -to-high adherent to their antihypertensive
regimen.
• MMAS includes questions on multiple reasons for non-adherence; e.g., a complex regimen can lead to
non -compliance, thus the scale involves a question evaluating whether the patients feel stressed
about their regimen. The patients generally give positive answers to please their HCP (Health Care
Personnel), hence the questions in Morisky’s study were formulated to avoid this partiality.
• Each question in MMAS evaluates a specific medication -taking behaviour, instead of adherence or
compliance behaviour. Morisky’s medication adherence scale comprises of the following questions:
• 1) Do you sometimes forget to take your high-BP pills?
• 2) Over the past 2 weeks, were there any days you did not take your high -BP medication?
• 3) Have you ever cut back or stopped taking your medication without telling your doctor because you
felt worse when you took it?
• 4) When you travel or leave home, do you sometimes forget to carry your medication with you?
• 5) Did you take your high-BP medication yesterday?
• 6) When you feel that your BP is under control, do you sometimes stop taking your medication?
• 7) Taking medication every day is real inconvenience for some people. Do you ever feel stressed about
sticking to your BP treatment plan?
• 8) How often do you have difficulty remembering to take your BP medication?
8/25/2022 15
PHARMACY PRACTICE
16. • Medication possession ratio and the proportion of days covered methods
(defined by the number of doses dispensed in relation to a dispensing period) are
the most commonly used measures of medication adherence based on pharmacy
data.
• The major difference between these two measures is that the medication
possession ratio accounts for oversupplies and have a value >1, whereas the
maximum proportion of days covered is 1, indicating full adherence .
• Using a pharmacy prescription refill data requires that patients should obtain
their medications in a closed pharmacy system.
• The medication possession ratio and the proportion of days covered methods of
evaluating medication adherence are correlated with the quantity of doses taken
(but not to the timing of doses). Also, adherence assessment with these
measures is more difficult when the length of follow-up varies between patients.
8/25/2022 16
PHARMACY PRACTICE
17. • Calculating Adherence
• There are various calculations for determining adherence based on pharmacy
claims data; however, no single approach has been uniformly acknowledged.
Medication Possession Ratio (MPR)
• MPR = LastFillDate – FirstFillDate LastFillDay'sSupply TotalDay'sSupplyin Period
• The value of MPR ranges from 0 to 1, of which 1 indicates 100% adherence. If
patients take early refills or they have only filled the medication once, the MPR
value can be >1.
• Medication Persistence
• Medication persistence is the denominator of the MPR equation and is used to
calculate the duration for which the patient has been taking the medication,
without considering any breaks in the therapy.
• Persistence = Last Fill Date – First Fill Date + Last Fill Day’s Supply
8/25/2022 17
PHARMACY PRACTICE
18. • Proportion of Days Covered (PDC)
• PDC = Number of Days in Period DIVIDED BY Number of Days in
Period Covered
• The value of PDC ranges from 0 to 1, of which 1 indicates 100%
adherence .
• The Pharmacy Quality Alliance (PQA) recomme nds that PDC can be
used for assessing adherence.
• The organisation determined that PDC gives a more conservative
estimate, particularly when medications are frequently switched.
• These metrics define adherence as >0.8 or 80% of days covered .
Medications fo r HIV/AIDS and birth control require approximately
100% adherence for effectiveness.
8/25/2022 18
PHARMACY PRACTICE
19. ROLE OF PHARMACIST
• The information that pharmacists should impart to the patients includes:
• 1) The name and purpose of medication,
• 2) The method and time of taking the medication,
• 3) Possible side effects that may occur,
• 4) Necessary precautions to be taken,
• 5) Interactions with food or other drugs,
• 6) The duration of therapy,
• 7) The action to be taken on missing a dose, and 8) How to tell whether or
not the medication is working.
8/25/2022 19
PHARMACY PRACTICE
20. • The patient-pharmacist relationship can be improved by the following strategies:
• The pharmacist should be friendly and approachable AND improve his/her communication skills,
• The pharmacist should consider psychological needs of the patient AND improve patient
education,
• The pharmacist should encourage the patients to discuss their concerns without interruption or
premature closing,
• The pharmacist should elicit patient’s perception of illness and associated feelings and
expectations,
• The pharmacist should learn methods of active listing and empathy,
• The pharmacist should give clear explanations AND check patient’s understanding level,
• The pharmacist should discuss a treatment plan,
• The pharmacist should check the patient’s attention to medication adherence,
• The pharmacist should make the therapeutic regimen easy AND conscious of patient’s wishes,
• The pharmacist should involve the patient in treatment decisions
8/25/2022 20
PHARMACY PRACTICE
21. • Apart from patient education, pharmacists also improve medication adherence
by serving the role of an advisor to prescribers on simplification of drug regimens,
by providing medication cards or medication aids (such as a dosette) to the
patients, and by identifying predisposing, enabling and reinforcing factors
contributing towards medication non - adherence.
• The clinical pharmacists in hospitals should measure the factors assisting in
medication adherence. Patient interviews help them to judge the patients’ know
ledge on drug therapy and their usual medication habits.
8/25/2022 21
PHARMACY PRACTICE
22. PATIENT MEDICATION HISTORY
INTERVIEW
• Medication history interview involves i nterviewing a patient for
collecting the data medical history.
• The history attained by the medical team and the pharmacist may
differ and fall into two categories, i.e.,
• intentional (when medical team makes a decision of changing the
regimen) or
• unintentional (when complete record was not available). Differences
should be clarified with the prescriber or the senior pharmacist.
8/25/2022 22
PHARMACY PRACTICE
24. • Pharmacists may obtain complete medication histories by their better knowledge. In order to get
detailed information, he/she should interview in a prede termined and systematic manner:
1) Firstly the pharmacist should get familiarise with the patient charts to know the present medical
status and background particulars of the patient.
2) The interview should be started with introduction and the reason for interview.
3) The patient’s name, address, age, and past medication history should be jotted down.
4) Direct or indirect questions can be put forward on primary issues , like prescribed medication,
self-medication, allergies, undesirable effect of any drug, compliance to prescribed medication, and
smoking, drinking and eating habits.
5) The language or terminologies should be simple and eas y to understand by the patient.
6) If the patient has difficulty in understanding specific terms, the pharmac ist should explain it
properly.
7) Secondary relevant areas for questioning are constipation, diarrhoea, cough and cold, lay fever,
allergies, vitamins, tonics and skin preparations.
8) At last , when patient’s confidence is achieved by the pharmacist through the interview,
questions on patient’s medication compliance could be asked. It is supportive information for the
drug therapy.
9) All the details gained duri ng the interview are noted down in a sheet, one copy of which is sent
to the physician
8/25/2022 24
PHARMACY PRACTICE
25. Need for the Patient Medication History Interview
1) It gives information about the drugs taken by the patient in the past or being taken at the present
time. Information on the responses of drugs administered in the past help
in planning the future treatment.
2) It informs about the drug effects, as drugs may give rise to a disease either directly or due to an
interaction.
3) The drugs the patient is currently taking can mask clinical signs; for example ,
β_x0002_adrenoceptor antagonists prevent tachycardi a in a patient with
haemorrhage;corticosteroids prevent abdo minal pain and rigidity in a patient with perforated
duodenal ulcer.
4) Drugs the patient is currently taking can also affect the results of diagnosis ; for example,
amiodarone alters the results of thyroid tests.
5) It helps to educate patients about their medications.
6) An inaccurate history on admission to hospital results in unwanted duplication of drugs, drug
interactions, discontinuation of long -term medications, and failure to detect drug -related
problems.Such prescription errors can be prevented by medication history.
8/25/2022 25
PHARMACY PRACTICE
26. Steps Involved and Data to be Obtained
• While interviewing the patients about their medication history, the pharmacists should
• follow the given procedure:
• 1) Patient Selection: The pharmacist should identify the patients who are likely to be benefitted from the interview.
• 2) Self-Preparation: The pharmacist should understand the medical condition of patients and also their therapy
before beginning the interview.
• 3) Introduction: The pharmacist should introduce himself/herself and explain thepurpose of interview to the
patients.
• 4) Conduct Interview: The pharmacist should collect all significant information using various open-and close-ended
questions.
• 5) Conclusion: The pharmacist should prepare a summary of all the important is sues and give clarification for the
same.
• 6) Documentation: The pharmacist should document the information gathered during the medication history
interview for future reference.
8/25/2022 26
PHARMACY PRACTICE
27. Reference
• Thakur publication book of Pharmacy practice by Dr. S. Tyagi et al,
2020.
• Images and data -Google sources
8/25/2022 PHARMACY PRACTICE 27